The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variant.
Related Research units
Bibliographical data
Original language | English |
---|---|
Article number | 1 |
ISSN | 0167-6806 |
Publication status | Published - 2012 |
pubmed | 22037784 |
---|